LAURUSLABSLaurus Labs Ltd.

    Laurus Labs Ltd: results and news

    Every Laurus Labs Ltd filing with the NSE and BSE that Blacklitt has written about, explained in plain words and linked to the filing, newest first: mergers & acquisitions, earnings.

    3 articles · pharmaceuticals and chemicals · Latest 29 Oct 2026

    LAURUSLABSLaurus Labs Ltd

    Laurus Labs invests ₹107.8 crore in joint venture KRKA Pharma through a rights issue, keeping its 49% stake

    Laurus Labs Limited has told the exchanges that it has invested ₹107.8 crore (₹1,078,000,000) in KRKA Pharma Private Limited, a joint venture between KRKA d.d., Novo mesto, Slovenia, and Laurus Labs. The company bought 10,78,00,000 equity shares of KRKA Pharma with a face value of ₹10 each, at face value, through a rights issue.

    • Mergers & acquisitions
    • Pharmaceuticals

    Blacklitt Research1 min read